Promakhos Therapeutics
ActiveA therapeutics platform for curing inflammatory disorders
What it does
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Its site says now · captured 2026-08-23
Promakhos Therapeutics
A Boston-based biotech startup developing medicines for patients with autoinflammatory disease.
Next to it in Healthcare and bio · bacterial therapeutics for inflammation
- Humane GenomicsY Combinator S21
A platform to make artificial viruses as cancer therapeutics.
- MatrubialsY Combinator S21
Developing milk-inspired therapeutics for infectious diseases
- TippingPoint BiosciencesSOSV SOSV IndieBio SF 14
First ever therapeutics for cancers driven by aberrant chromatin networks
- ViAn TherapeuticsSOSV SOSV IndieBio SF 14
Topical antiangiogenic peptide for retinal vascular diseases
- Entelexo BiotherapeuticsY Combinator W21
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
- Laguna BioSOSV SOSV IndieBio SF 13
Next generation bispecific antibody cancer therapy.
- DisperseBioSOSV SOSV IndieBio SF 16
Disrupting biofilms
- Gilgamesh PharmaceuticalsY Combinator S20
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…